Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
2.
Rev. méd. Chile ; 137(2): 275-279, feb. 2009. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-516095

RESUMO

Osteonecrosis of the jaw associated to biphosphonate use is more common in cancer patients with bone metastases, that are using intravenous diphosphonates. When these drugs are used orally the risk of the complication is lower. We report 3 diabetic women aged 69, 76 and 82 years, receiving alendronate 70 mg every one week. The unveiling event was the extraction of several teeth without the use of antibiotics. All had bone pain, purulent discharge, loss of bone and halitosis. All improved five months after discontinuing alendronate.


Assuntos
Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Alendronato/efeitos adversos , Conservadores da Densidade Óssea/efeitos adversos , Doenças Maxilomandibulares/induzido quimicamente , Osteonecrose/induzido quimicamente , /tratamento farmacológico , Doenças Maxilares/induzido quimicamente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA